Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MaxCyte
MaxCyte
Six more biotechs price public debuts just before the start of the weekend
Endpoints
Fri, 07/30/21 - 12:15 pm
IPOs
Tenaya Therapeutics
Immuneering
Rani Therapeutics
IN8Bio
Omega Therapeutics
MaxCyte
Highlights: American Society of Gene & Cell Therapy Meeting
BioSpace
Fri, 05/3/19 - 10:54 pm
gene therapy
cell therapy
Audentes Therapeutics
MaxCyte
Moderna Therapeutics
Translate Bio
Homology Medicines
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte
Fierce Biotech
Sat, 03/2/19 - 12:42 pm
Gilead Sciences
Kite Pharma
CAR-T
MaxCyte
CRISPR, MaxCyte expand partnership into immuno-oncology
Pharmaceutical Business Review
Tue, 11/13/18 - 09:47 am
CRISPR Therapeutics
MaxCyte
immuno-oncology
gene editing
MaxCyte begins dosing in phase I solid tumors clinical trial
Pharmaceutical Business Review
Thu, 10/11/18 - 09:41 am
MaxCyte
MCY-M11
relapsed/refractory ovarian cancer
ovarian cancer
peritoneal mesothelioma
solid tumors